Preferred Label : IL6 Signaling Pathway;
NCIt related terms : IL 6 signaling pathway;
Alternative definition : BIOCARTA: Interleukin-6 (IL-6) is a cytokine that provokes a broad range of cellular
and physiological responses. In addition to playing a role in inflammation and hematopoiesis,
IL-6 is involved in other processes such as neuronal differentiation and bone loss.
To produce these effects IL-6 signals through a receptor composed of two different
subunits, an alpha subunit that produces ligand specificity and gp130, a receptor
subunit shared in common with other cytokines in the IL-6 family. Binding of IL-6
to its receptor initiates cellular events including activation of JAK kinases and
activation of ras-mediated signaling. Activated JAK kinases phosphorylate and activate
STAT transcription factors, particularly STAT3, that move into the nucleus to activate
transcription of genes containing STAT3 response elements. The ras-mediated pathway,
acting through Shc, Grb-2 and Sos-1 upstream and activating Map kinases downstream,
activates transcription factors such as ELK-1 and NF-IL-6 (C/EBP-beta) that can act
through their own cognate response elements in the genome. These factors and other
transcription factors like AP-1 and SRF (serum response factor) that respond to many
different signaling pathways come together to regulate a variety of complex promoters
and enhancers that respond to IL-6 and other signaling factors. (This definition may
be outdated - see the DesignNote.);
NCIt note : The BIOCARTA Definition (ALT_DEFINITION) for this pathway concept was provided by
BioCarta. This property was not created by, nor is it maintained by the NCI Thesaurus
staff. Additionally, BioCarta is no longer updating its pathway data; thus, the BIOCARTA
Definition might be outdated or inaccurate. Please see the Terms and Conditions for
Use at http://www.biocarta.com/.;
Biocarta ID : h_il6Pathway;
Origin ID : C39127;
UMLS CUI : C1512598;
Semantic type(s)
has_gene_product_element
pathway_has_gene_element